
# Title 42 - Public Health
## Chapter I - Public Health Service, Department of Health and Human Services
### Subchapter J - Vaccines
#### PART 110 - COUNTERMEASURES INJURY COMPENSATION PROGRAM
##### Subpart K - Covered Countermeasures Injury Tables
###### ยง 110.100 Injury Tables.
####### Vasovagal syncope.,sequelae.,sequelae

(2)Vasovagal syncope (also sometimes called neurocardiogenic syncope) means loss of consciousness (fainting) and loss of postural tone caused by a transient decrease in blood flow to the brain occurring after the administration of an injected countermeasure. Vasovagal syncope is usually a benign condition, but may result in falling and injury with significantVasovagal syncope may be preceded by symptoms, such as nausea, lightheadedness, diaphoresis (sweating), and/or pallor. Vasovagal syncope may be associated with transient seizure-like activity, but recovery of orientation and consciousness generally occurs simultaneously. Loss of consciousness resulting from the following conditions will not be considered vasovagal syncope: Organic heart disease, cardiac arrhythmias, transient ischemic attacks, hyperventilation, metabolic conditions, neurological conditions, psychiatric conditions, seizures, trauma, and situational as can occur with urination, defecation, or cough. This list is not complete as other conditions that are not associated with the vaccine also may cause loss of consciousness. Episodes of recurrent syncope occurring after the applicable timeframe are not considered to beof an episode of syncope meeting the Table 2 requirements.
